TEM's Genomics unit is expected to report strong growth for the fourth quarter, banking on continued unit growth pick-up.

Coming to the latest development around Olivia, the investors are optimistic, evident from the stock surge last week.

In a regulatory filing on Friday, Tempus AI (TEM) disclosed that Chairman and CEO Eric Lefkofsky sold a series of shares beginning on January ...

Just 10 days after Pelosi’s AI stock acquisition, the chief executive officer (CEO) of the company dumped $62 million worth ...

We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look ...

Cathie Wood, head of ARK Investment Management, usually targets tech stocks that she says have a disruptive impact, even if ...

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free ...

In the trial, patients who received a once-weekly 20 mg injection of amycretin over 36 weeks saw an impressive 22% reduction ...

No, public service shouldn’t require a vow of poverty. But when electeds get rich off stock trades based on inside info, it’s ...

Tempus AI’s diagnostic platform drives growth, but US healthcare reimbursement remains a hurdle. Learn why TEM stock is worth ...

Stock trades involving some of the world’s largest tech companies were disclosed by former House Speaker Nancy Pelosi. While Congress continues to debate banning lawmakers and their […] ...

Tempus AI Inc (TEM) stock saw a modest uptick, ending the day at $50.45 which represents a slight increase of $2.81 or 5.90% from the prior close of $47.64. The stock opened at $51.67 and touched a ...